Drug misuse and dependency

Services

NDTMS: community combined review forms

Combined Review Forms (CRF) for community treatment services to use for Core Dataset P (CDS-P), from April 2020 onwards.
Drugs Test 1 (DT1) form

Form for the testing of specified class A drugs on persons ages 18 or over.
NDTMS: secure setting outcomes forms

Outcome monitoring forms for use by secure setting from April 2020 for core dataset P.

Controlled drugs list
- Guidance
- 8 August 2022
- Home Office
Drug misuse and dependence: UK guidelines on clinical management
- Guidance
- 15 December 2017
- Department of Health and Social Care
FRANK: free practical drug advice for adults and children
- Guidance
- 8 April 2013
- Home Office
Extra funding for drug and alcohol treatment: 2023 to 2025
- Guidance
- 16 February 2023
- Office for Health Improvement and Disparities
Drug strategy housing support funding: allocations 2022 to 2025
- Guidance
- 29 November 2023
- Office for Health Improvement and Disparities

£267 million to boost local drug and alcohol treatment
- 13 November 2023
- Department of Health and Social Care
- Press release
Barriers to research with synthetic cannabinoid receptor agonists
- 23 October 2023
- Home Office and Advisory Council on the Misuse of Drugs
- Correspondence
Immigration offender tries to escape cannabis farm before arrest
- 5 October 2023
- Home Office and Immigration Enforcement
- News story
Response to ACMD advice on NHS England electronic prescribing proposal
- 29 September 2023
- Home Office and Advisory Council on the Misuse of Drugs
- Correspondence
Reappointments to the Advisory Council on the Misuse of Drugs
- 4 September 2023
- Advisory Council on the Misuse of Drugs
- News story

Opiate and crack cocaine use: prevalence estimates by local area
- 24 October 2023
- Closed organisation: Public Health England
- Research
Opiate and crack cocaine use: prevalence estimates
- 24 October 2023
- Office for Health Improvement and Disparities and UK Health Security Agency
- Research
Substance misuse treatment for adults: statistics 2021 to 2022
- 4 October 2023
- Office for Health Improvement and Disparities
- National statistics
ACMD Naloxone Review
- 26 September 2023
- Advisory Council on the Misuse of Drugs
- Research
Advice on scheduling and lawful access to nitrous oxide
- 5 September 2023
- Advisory Council on the Misuse of Drugs
- Research

Nitrous oxide: legitimate uses and appropriate controls
- 5 September 2023
- Home Office
- Consultation outcome
- Date closed 28 June 2023
Expanding access to naloxone
- 15 March 2022
- Department of Health and Social Care
- Closed consultation
- Date closed 28 September 2021
ACMD internet-facilitated drug markets review
- 17 November 2023
- Home Office and Advisory Council on the Misuse of Drugs
- Open call for evidence
Drug use in ethnic minority groups
- 21 September 2023
- Home Office and Advisory Council on the Misuse of Drugs
- Open call for evidence
From harm to hope: A 10-year drugs plan to cut crime and save lives
- 29 April 2022
- Home Office, Department of Health and Social Care, Ministry of Justice, Department for Work and Pensions, Department for Education, and Department for Levelling Up, Housing and Communities
- Policy paper

Drug Testing on Arrest (DToA): programme data
- 25 August 2023
- Home Office
- Transparency
From harm to hope: first annual report 2022 to 2023
- 20 July 2023
- Home Office
- Corporate report
Rough sleeping drug and alcohol treatment grant: privacy notice
- 22 July 2022
- Office for Health Improvement and Disparities
- Corporate report
Doctor licensing for diamorphine prescribing: privacy notice
- 22 July 2022
- Office for Health Improvement and Disparities
- Corporate report
Individual Placement and Support (IPS-AD) trial: privacy notice
- 28 January 2022
- Office for Health Improvement and Disparities
- Corporate report